Getinge (GETI B.ST) Aktsia Kursus
Getinge Kursus
Käive kasvas 5,3 % aastas viimase 19 aasta jooksul 34,97 B SEK-ni. Kasum aktsia kohta kasvas 3,1 % aastas viimase 19 aasta jooksul. Getinge netomarginaal on nüüd 6,5 %, langenud 11,0 %-lt mõni aasta tagasi. Getinge pakub praegu umbes 1,65 % dividenditootlust. Väljamaksesuhe on umbes 55 % kasumist. Dividend kasvas 4,7 % aastas viimase 19 aasta jooksul. Analüütikute hinnasihi mediaan on 231,03 SEK, st alla praegust hinda 17,2 %. 14 analüütikust 8 soovitab osta — üldine konsensus on Osta.
Getinge aktsiahinnad
Hangi need andmed Eulerpool API kaudu
100 000 päringut/kuus tasuta · krediitkaarti pole
Getinge ärimudel ja aktsia analüüs
Korduma kippuvad küsimused Getinge aktsia kohta
Getinge AB is a global medical technology company that specializes in providing solutions for hospitals and healthcare organizations. The business model of Getinge AB revolves around offering innovative products, systems, and services within areas such as surgical workflows, patient care, and infection control. They strive to improve patient outcomes and enable healthcare professionals to deliver efficient and safe care. With a focus on providing high-quality medical equipment and integrated solutions, Getinge AB aims to enhance the overall healthcare experience.
Getinge AB is primarily active in the healthcare industry.
The main competitors of Getinge AB in the market include leading medical technology companies such as Medtronic, Johnson & Johnson, and Siemens Healthineers. These companies also provide a wide range of innovative medical devices and solutions, competing with Getinge AB in areas such as surgical equipment, patient handling systems, and infection control products. Getinge AB, as a global provider of medical technology, faces intense competition in its quest to deliver advanced healthcare solutions to customers worldwide.
Getinge AB, a renowned Swedish company, has a rich history and a strong background in the healthcare industry. Established in 1904, Getinge has evolved into a global leader in medical technology, providing innovative solutions for infection control and surgical workflows. With a primary focus on improving patient outcomes and enhancing healthcare efficiency, Getinge offers a wide range of products and services, including advanced medical equipment, such as surgical tables, anesthesia systems, and sterilization equipment. Over the years, Getinge has expanded its operations internationally, becoming a trusted partner for healthcare institutions worldwide. Through continuous innovation and dedication to healthcare excellence, Getinge AB has firmly established itself as a leading player in the global medical technology market.
Getinge AB has achieved several significant milestones throughout its history. One major accomplishment was the acquisition of Maquet in 2000, which expanded the company's portfolio and global reach. In 2006, Getinge AB successfully listed its shares on the Stockholm Stock Exchange, strengthening its position in the market. The company has also made substantial progress in research and development, introducing innovative medical technology solutions for healthcare professionals worldwide. Additionally, Getinge AB has focused on sustainability initiatives, committing to reducing its carbon footprint and promoting environmentally friendly practices. These milestones demonstrate Getinge AB's commitment to growth, innovation, and sustainability in the healthcare industry.
Getinge AB, a renowned global medical technology company based in Sweden, operates in multiple countries and regions worldwide. With a strong international presence, Getinge AB extends its operations across various continents, including Europe, Asia, North America, and Latin America. The company establishes its footprint in countries such as Sweden, Germany, France, the United States, China, Brazil, and many more. Through its extensive network and subsidiaries, Getinge AB serves customers across the globe, contributing to the advancement of healthcare and improving patient outcomes.
Getinge AB is committed to upholding certain values and corporate philosophy. The company believes in promoting patient safety and enhancing healthcare outcomes. They prioritize quality in their products and services, ensuring efficient and reliable medical solutions. Getinge AB strives for sustainability by minimizing the environmental impact of their operations and products. They value transparency, integrity, and accountability in their business practices. Getinge AB consistently focuses on innovation and advancement in the healthcare industry, aiming to improve patients' lives worldwide. With their dedication to their mission and values, Getinge AB continues to be a trusted and influential player in the medical technology sector.
Analüütikud määravad Getinge aktsiale keskmiseks hinnasihi 238,81 SEK (mediaan: 231,03 SEK), mis on −12,5 % viimase hinna suhtes. Konsensus põhineb 14 analüütiku hinnangul.
14 analüütikut hindavad praegu Getinge aktsiat: 8 soovitab osta, 5 hoida ja 1 müüa. 2026. aastaks ootavad analüütikud, et Getinge teenib tulu 35,26 B SEK ja kasumit aktsia kohta 12,89 SEK.
Praeguse kursiga kaubeldakse Getinge aktsiaga 25,48 EUR (279,00 SEK) juures.
Getinge aktsia (GETI B.ST) on noteeritud 9 börsil, sh: London (0GZV.L), SIX (Zürich) (GETIB.SW), Frankfurt (GTN.F), München (GTN.MU), Düsseldorf (GTN.DU), Stockholm (GETI B.ST).
Getinge AB is a Swedish company specializing in the manufacturing of medical devices and solutions. The company operates in three main areas: Acute Care Therapies, Life Science, and Surgical Workflows. Getinge offers products and services to improve patient care and enhance the efficiency and profitability of hospitals and medical facilities. They provide solutions for critical care situations, infection prevention and control, as well as for the life sciences, pharmaceutical, and food industries. Getinge also offers products and solutions for surgical workflows, including cleaning, disinfection, sterilization, and training services. The company follows a value-based healthcare model, aiming to provide value to customers by ensuring optimal patient treatment and economic responsibility. With a focus on continuous innovation, Getinge strives to meet the evolving needs of its customers as a global leader in the medical technology industry.
oodatav Getinge käive on 35,26 B SEK. See näitaja põhineb praegusel finantsandmetel ja peegeldab ettevõtte äritulemuseid.
oodatav Getinge kasum on 3,51 B SEK. Netokasum peegeldab ettevõtte kasumlikkust pärast kõigi kulude mahaarvamist.
Võrdlusarvud hinna ja kasumiga (P/E) Getinge jaoks on praegu 21,65. P/E-suhtarv võrdleb praegust aktsiahinnad kasumiga aktsia kohta ja aitab investoritel hinnata Getinge aktsia väärtust.
Kursuse ja müügimahu suhe (P/S) Getinge jaoks on praegu 2,16. P/S-suhtarv võrdleb börsikapitalisatsooni aastase tuluga ja teenib hindamismõõdikuna Getinge aktsia jaoks.
Eulpooli kvaliteedinäitaja Getinge jaoks on 4/10.
Getinge ISIN on SE0000202624. ISIN (rahvusvaheline väärtpaberi identifitseerimise number) on väärtpaberite globaalne unikaalne tuvastaja.
Getinge WKN on 889714. WKN (Wertpapierkennnummer) on kuuekohaline saksa väärtpaberi identifitseerimise number.
Getinge ticker on GETI B.ST. Ticker-sümbol kasutatakse Getinge aktsiate kauplemiseks börsil.
Getinge aktsia
Getinge konkurendid
Getinge Börsiticker
Getinge FIGI
Kõik teised näitajad ja analüüsid Getinge kohta sügavamalt
Meie Getinge-aktsia analüüs sisaldab olulisi finantsnäitajaid, nagu käive, kasum, P/E suhe, P/S suhe, EBIT, samuti teavet dividendi kohta. Lisaks käsitleme aspekte nagu aktsiad, turukapitalisatsioon, võlad, omakapital ja kohustused ettevõttes Getinge. Kui otsite nende teemade kohta põhjalikumat teavet, pakume teile meie alamlehtedel üksikasjalikke analüüse: